Dr Lee Sam Goo
Former Research Professor
CEO, 239Bio Inc.
South Korea
Biography
Dr Lee Sam Goo is the CEO of 239bio Inc., which is located at Southern part of JeonBuk Province, South Korea. He has successfully accomplished the research related for “Regeneration of Pancreatic Beta-Cells Destroyed†using ‘D&D’ in T1DM. Dr. Lee showed this revolutionary efficacy on Diabetes from 14 groups of 180 T1DM rats induced by Streptozotocin. Those scientific revolutionary regenerationof beta cells destroyed was conducted by AAALAC at ChonBuk National University in Republic of Korea and proven scientifically every biomarkers such as C-peptide, Insulin secretion, Bax, Bcl-2, Cleaved caspase-3, HbA1c, no side effects in Liver and Kidney included, FBG, PP2, ITT andGTT etc.,. Dr. Lee’s researches are not limited to non-clinical trials, but made a much better achievements in human trials. Even T1DM patients showed remarkable recoveries from the worst cases of DM and became normalized of their C-Peptide and Insulin levels after 1 year of D&D trials.
Research Interest
Diabetes and Metabolic Disorders